The Comparison of a Technology-Based System and an In-Person Behavioral Weight Loss Intervention
4. august 2015 oppdatert av: John M. Jakicic, PhD
The primary aim of this study is to compare the changes in body weight between a technology-based system, an in-person behavioral weight loss intervention, and a combination of both during a 12 month behavioral weight loss intervention in adults.
Sedentary, healthy overweight and obese adults will be recruited to participate.
Assessments will be conducted at 0, 6, and 12 months.
This is a randomized trial in which participants will be randomized to one of three groups: standard behavioral weight loss (SBWL), standard behavioral weight loss plus technology (SBWL+TECH), and technology alone alone (TECH).
Studieoversikt
Status
Fullført
Forhold
Studietype
Intervensjonell
Registrering (Faktiske)
51
Fase
- Fase 2
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Forente stater, 15260
- University of Pittsburgh
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år til 55 år (Voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- ages of 21-55 years
- Body mass index (BMI) between 25-39.9 kg/m2
Exclusion Criteria:
- Currently pregnant, pregnant in the last 6 months, or plan on becoming pregnant in the next 6 months.
- Currently participating in regular exercise for over 60 minutes/week.
- Taking any medications that affect body weight or metabolism (e.g. synthroid).
- Have any physical limitations that would prevent exercise.
- Currently being treated for coronary heart disease, diabetes mellitus, hypertension, or cancer.
- Have a history of myocardial infarction or other heart-related surgeries.
- Have a resting systolic blood pressure > 150 mmHg or diastolic blood pressure of > 100 mmHg or currently taking any medications that affect blood pressure or heart rate (e.g. beta blockers).
- Currently enrolled in a commercial weight loss program, participating in another weight loss study, or in a weight loss study in the last 12 months.
- Have lost > 5% of current body weight in the past 6 months.
- Currently being treated for any psychological problems or taking any psychotropic medication.
- Currently do not have access to a computer and the Internet that can be used for this study. This requires a PC computer, the ability to load software for the technology system, an existing internet connection provided by the participant, and a dedicated USB port to allow the armband from the technology system to be connected to the computer for the download of information.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Standard weight loss intervention
|
In-person weight loss sessions, dietary intake prescription of 1200-1500 kcal per day, exercise progressing to 300 minutes per week.
|
|
Eksperimentell: Standard weight loss intervention plus technology
|
In-person weight loss sessions, dietary intake prescription of 1200-1500 kcal per day, exercise progressing to 300 minutes per week, plus technology to provide real-time feedback on energy expenditure, plus a website to log dietary intake.
|
|
Eksperimentell: Technology only
|
One intervention telephone call per month, dietary intake prescription of 1200-1500 kcal per day, exercise progressing to 300 minutes per week, plus technology to provide real-time feedback on energy expenditure, plus a website to log dietary intake.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
weight
Tidsramme: change from 0 to 6 months
|
Body weight will be assessed on a digital scale to assess change in body weight over the intervention period.
|
change from 0 to 6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
cardiorespiratory fitness
Tidsramme: 0, 6, 12, months
|
A graded exercise test on a treadmill along with indirect calorimetry will be used to measure cardiorespiratory fitness.
This will provide a measure of oxygen consumption and metabolic equivalents of work at the time of test termination.
|
0, 6, 12, months
|
|
body composition
Tidsramme: 0, 6, 12 months
|
Body composition will be assessed using dual energy X-ray absorptiometry (DXA).
This will provide a measure of lean body mass, fat mass, bone mineral content, and percent body fat.
|
0, 6, 12 months
|
|
physical activity
Tidsramme: 0, 6, 12 months
|
A questionnaire and a portable device worn on the upper arm will be used to measure and quantify energy expenditure from physical activity.
|
0, 6, 12 months
|
|
dietary intake
Tidsramme: 0, 6, 12 months
|
A questionnaire will be used to assess self-reported food intake.
This will be used to estimate calories, dietary fat, protein, and carbohydrates consumed.
|
0, 6, 12 months
|
|
psychosocial and behavioral measures
Tidsramme: 0, 6, 12 months
|
Questionnaires will be used to assess self-efficacy for weight loss and physical activity, barriers to physical activity and weight loss, expected outcomes resulting from physical activity and weight loss, perceived body image, depressive symptomotology, weight history, dietary disinhibition and restraint, and behaviors typically related to weight loss (e.g., self-weighing, meal planning, etc.).
|
0, 6, 12 months
|
|
Weight change
Tidsramme: weight at 0, 6, and 12 months
|
Body weight measured on a digital scale
|
weight at 0, 6, and 12 months
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Studieleder: Steve Verba, MS, University of Pittsburgh
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. august 2009
Primær fullføring (Faktiske)
1. september 2010
Studiet fullført (Faktiske)
1. september 2010
Datoer for studieregistrering
Først innsendt
25. mai 2010
Først innsendt som oppfylte QC-kriteriene
28. mai 2010
Først lagt ut (Anslag)
2. juni 2010
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
5. august 2015
Siste oppdatering sendt inn som oppfylte QC-kriteriene
4. august 2015
Sist bekreftet
1. august 2015
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- PRO09040121
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .